Filtered through the analytical power of artificial intelligence, the wealth of available biomedical data promises to revolutionize cancer research, diagnosis and care. In this Viewpoint, six experts discuss some of the challenges, exciting developments and future questions arising at the interface of machine learning and oncology.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer
BMC Cancer Open Access 30 July 2022
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
The authors declare no competing interests.
About this article
Cite this article
Troyanskaya, O., Trajanoski, Z., Carpenter, A. et al. Artificial intelligence and cancer. Nat Cancer 1, 149–152 (2020). https://doi.org/10.1038/s43018-020-0034-6